Long-term positive airway pressure therapy is associated with reduced total cholesterol levels in patients with obstructive sleep apnea: data from the European Sleep Apnea Database (ESADA)
Makaleler > Tam Makale · 2020
Yazarlar: Canan Gunduz, Özen KAÇMAZ BAŞOĞLU, John Arthur Kvamme, Johan Verbraecken, Ulla Anttalainen, Oreste Marrone, Paschalis Steiropoulos, Gabriel Roisman, Pavol Joppa, Holger Hein, Georgia Trakada, Jan Hedner, Ludger Grote
Sleep Medicine, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Wos, 2020, cilt 75, ss 201-209
DOI: 10.1016/j.sleep.2020.02.023
Özet
Background and aim: Obstructive sleep apnea (OSA) is an independent risk factor for dyslipidemia. The current study examined the effects of positive airway pressure (PAP) treatment on lipid status in the European Sleep Apnea Database (ESADA).